Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Putative nuclear cdk2 substrates in normal and transformed cells

M Jaumot1, N Agell, O Bachs

  • 1Department of Cell Biology, Faculty of Medicine, University of Barcelona, Spain.

Biochemical and Biophysical Research Communications
|February 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluation.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

p27<sup>Kip1</sup> represses the Pitx2-mediated expression of p21<sup>Cip1</sup> and regulates DNA replication during cell cycle progression.

Oncogene·2016
Same author

p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.

Oncogene·2011
Same author

K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function.

Oncogene·2010
Same author

Degradation of cyclin A is regulated by acetylation.

Oncogene·2009
Same author

Qualitative evaluation of chromatographic data from quality control schemes using a support vector machine.

The Analyst·2007

Researchers identified distinct nuclear cyclin-dependent kinase 2 (CDK2) substrates in normal versus transformed cells. Normal cells share specific CDK2 substrates, while transformed cells exhibit unique ones, offering insights into cell cycle regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinase 2 (CDK2) plays a crucial role in cell cycle progression.
  • Identifying CDK2 substrates is essential for understanding its regulatory functions in normal and cancer cells.
  • Nuclear CDK2 activity is implicated in various cellular processes, including DNA replication and repair.

Purpose of the Study:

  • To identify and characterize putative nuclear substrates of CDK2 in different cell types.
  • To compare the CDK2 substrate profiles between normal and transformed cellular systems.
  • To investigate potential differences in CDK2 substrate composition related to cellular proliferation and transformation.

Main Methods:

  • Nuclear fractions (S1) were isolated from normal (rat hepatocytes, human T lymphocytes) and transformed (HeLa, Namalwa) cell lines using DNase and RNase treatment.

Related Experiment Videos

  • Immunoprecipitation assays were performed using anti-CDK2 antibodies.
  • Phosphorylation assays were conducted to identify and analyze CDK2 substrates.

    • Main Results:

    • Normal cells (hepatocytes, lymphocytes) shared three common putative nuclear CDK2 substrates with molecular weights of 21, 37, and 57 kDa.
    • Transformed cell lines (HeLa, Namalwa) shared a distinct nuclear CDK2 substrate of 20 kDa.
    • Proliferating normal lymphocytes and the lymphoblastoid cell line Namalwa shared two proteins of 40 and 70 kDa, suggesting potential overlap or altered substrate profiles in certain contexts.

    Conclusions:

    • Distinct sets of nuclear CDK2 substrates characterize normal and transformed cells, indicating cell-type-specific regulation.
    • The identified substrates may serve as biomarkers for cellular transformation or proliferation status.
    • Further research into these specific CDK2 substrates could elucidate mechanisms underlying cell cycle control and oncogenesis.